The Politics of Blood. Ethics, Innovation and the Regulation of Risk.

Farrell, Anne-Maree

ISBN 10: 1107474795 / ISBN 13: 9781107474796

Published by Cambridge University Press, 2014

About this Item

This book explores the relationship between politics, ethics and law in risk governance involving multi-valued human biological materials, such as blood. Series: Cambridge Bioethics and Law. Num Pages: 284 pages, 1 b/w illus. BIC Classification: LNTM; PSAD. Category: (P) Professional & Vocational. Dimension: 230 x 152 x 13. Weight in Grams: 412. . 2014. Paperback. . . . . Books ship from the US and Ireland.

Seller Inventory # V9781107474796

Bibliographic Details

• Title: The Politics of Blood. Ethics, Innovation and the Regulation of Risk.
• Publisher: Cambridge University Press
• Publication Date: 2014
• Language: English
• ISBN 10: 1107474795
• ISBN 13: 9781107474796
• Binding: Soft cover
• Condition: New

About this title

Synopsis

How best to manage risk involving multi-valued human biological materials is the overarching theme of this book, which draws on the sourcing and supply of blood as a case study. Blood has ethical, social, scientific and commercial value. This multi-valuing process presents challenges in terms of managing risk, therefore making it ultimately a matter for political responsibility. This is highlighted through an examination of the circumstances that led to HIV blood contamination episodes in the US, England and France, as well as their consequences. The roles of scientific expertise and innovation in managing risks to the blood system are also analyzed, as is the increased use of precautionary and legal strategies in the post-HIV blood contamination era. Finally, consideration is given to a range of policy and legal strategies that should underpin effective risk governance involving multi-valued human biological materials.

About the Author

Anne-Maree Farrell is Associate Professor of Law at the Faculty of Law, Monash University, Melbourne. Her research expertise lies broadly within the area of health law and policy, with a particular interest in the regulatory governance of human biological materials. She previously practised as a lawyer for over ten years, specialising in medical-related litigation.